Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Anastrozole and CJC-1295 (without DAC) Interaction: Synergistic | Peptide Database

Can you take Anastrozole with CJC-1295 (without DAC)? Synergistic interaction (60% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Anastrozole with CJC-1295 (without DAC)?

Yes, Anastrozole and CJC-1295 (without DAC) can generally be taken together. CJC-1295 (without DAC) helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen.

Is Anastrozole and CJC-1295 (without DAC) safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between Anastrozole and CJC-1295 (without DAC)?

CJC-1295 (without DAC) helps manage estrogen conversion from Anastrozole. This is a common and recommended combination. Adjust AI dose based on bloodwork — avoid crashing estrogen. This assessment has 60% confidence and is inferred from pharmacological mechanism analysis.

How should I time Anastrozole and CJC-1295 (without DAC)?

Anastrozole has a half-life of ~40-50 hours and CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question